Non-alcoholic Steatohepatitis Market size is set to grow by USD 11.21 billion from 2023-2027, rising prevalence of obesity and metabolic syndrome to boost the market growth, Technavio

/PRNewswire/ -- The global non-alcoholic steatohepatitis market size is estimated to grow by USD 11.21 billion from 2023-2027, according to Technavio. The...

Related Keywords

Germany ,Canada ,United States ,China ,United Kingdom ,America ,Jesse Maida ,Company Analysis ,Intercept Pharmaceuticals Inc ,Madrigal Pharmaceuticals Inc ,Enzo Biochem Inc ,Research Analysis ,Market Research Overview ,Novo Nordisk ,Glaxosmithkline Plc ,Technavio Research ,Astrazeneca Plc ,Zydus Lifesciences Ltd ,Gilead Sciences Inc ,Company Landscape ,Zeneca Plc ,Cirius Therapeutics ,Prometheus Laboratories ,Siemens Healthineers ,Intercept Pharmaceuticals ,Non Alcoholic Steatohepatitis ,Technavio ,